Composition
- Active ingredients
- LASMIDITAN SUCCINATE EQ 100MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LASMIDITAN SUCCINATE EQ 100MG BASE · TabletThis page
- LASMIDITAN SUCCINATE EQ 200MG BASE · TabletNDA211280-003 · Discontinued
- LASMIDITAN SUCCINATE EQ 50MG BASE · TabletNDA211280-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA211280.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Reyvow
- Active substance
- lasmiditan succinate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Eli Lilly and Co
- Status
- Prescription
- FDA approval
- 11 Oct 2019
- Application
- NDA211280-002